Research

A collection of the latest research and findings in the respiratory space

Research

Filter by topic:

All Asthma COPD Research Bronchiectasis Lung cancer Obstructive sleep apnoea Housing Smoking Management plans Other conditions Access to primary care Health literacy Poverty Health workforce Social determinants IPF Vaping COVID-19

Prevalence and attributable health burden of chronic respiratory diseases, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017:

GBD Chronic Respiratory Disease Collaborators

1 June, 2020

Respiratory Research Review Issue 180

Mepolizumab effectiveness and identification of super-responders in severe asthma:

Erin S. Harvey, David Langton, Constance Katelaris, Sean Stevens, Claude S. Farah, Andrew Gillman, John Harrington, Mark Hew, Vicky Kritikos, et al.

21 May, 2020

Respiratory Research Review Issue 176

A Systematic Review of the Effect of Delayed Appropriate Antibiotic Treatment on the Outcomes of Patients With Severe Bacterial Infections:

Evan J. Zasowski, PharmD Matteo Bassetti, MD, PhD Francesco Blasi, MD, PhD Herman Goossens, PhD Jordi Rello, MD, PhD Giovanni Sotgiu, MD, PhD Lara Tavoschi, PhD Mick R. Arber, MA Rachael McCool, BSc Jacoby V. Patterson, MD Christopher M. Longshaw, PhD Sara Lopes, PharmD Davide Manissero, MD Sean T. Nguyen, PharmD Keiko Tone, MBA Stefano Aliberti, MD

21 May, 2020

NZ Respiratory Research Review Issue 184

Disease burden of eosinophilic airway disease: Comparing severeasthma, COPD and asthma–COPD overlap:

Sarah A. Hiles, Peter G. Gibson, Vanessa M. McDonald

19 May, 2020

NZ Respiratory Research Review Issue 186

Association Between Initiation of Pulmonary Rehabilitation After Hospitalization for COPD and 1-Year Survival Among Medicare Beneficiaries:

Peter K. Lindenauer, MD, MSc, Mihaela S. Stefan, MD, PhD, Penelope S. Pekow, PhD, et al

12 May, 2020

NZ Respiratory Research Review Issue 180

Adherence to inhaled corticosteroids and clinical outcomes in mepolizumab therapy for severe asthma:

Gráinne d'Ancona, Joanne Kavanagh, Cris Roxas, Linda Green, Mariana Fernandes et al.

7 May, 2020

Respiratory Research Review Issue 176

Bronchial thermoplasty versus mepolizumab: Comparison of outcomes in a severe asthma clinic:

David Langton Joy Sha Suzy Guo Julie Sharp Ceri Banks Wei Wang Virginia Plummer Francis Thien

4 May, 2020

NZ Respiratory Research Review Issue 182

Cost of hospitalization for bronchiectasis exacerbation in children:

Vikas Goyal,Steven M. McPhail,Frank Hurley,Keith Grimwood,Julie M. Marchant,I. Brent Masters,Anne B. Chang

1 May, 2020

NZ Respiratory Research Review Issue 191

Early-life antibiotic use and risk of asthma and eczema: results of a discordant twin study :

Elise M.A. Slob, Bronwyn K. Brew, Susanne J.H. Vijverberg, Chantal J.A.R. Kats , Cristina Longo, Mariëlle W. Pijnenburg, Toos C.E.M. van Beijsterveldt, Conor V. Dolan, Meike Bartels, Patrick Magnusson, Paul Lichtenstein, Tong Gong, Gerard H. Koppelman, Catarina Almqvist, Dorret I. Boomsma and Anke H. Maitland-van der Zee

23 April, 2020

Respiratory Research Review Issue 176

Overuse of short-acting β2-agonists in asthma is associated with increased risk of exacerbation and mortality: a nationwide cohort study of the global SABINA programme:

Bright I. Nwaru, Magnus Ekström, Pål Hasvold, Fredrik Wiklund, Gunilla Telg and Christer Janson

16 April, 2020

Respiratory Research Review Issue 176